Roberto Bianchi
Founder and Chairman

Highly experienced pharmaceutical and healthcare executive, having started in 1974 with Ellem, a small Italian pharmaceutical company of which he became shareholder and CEO and sold successfully to PharmItalia Carlo Erba in 1986.

Between 1986-1992 he was GM and then CEO of Farmitalia Carlo Erba. He was also appointed COO and then CEO of pharmaceutical business of Erbamont, the holding company of Montedison Group which owned Farmitalia Carlo Erba.

In 1993, he founded Aquisitio S.p.a, a financial company that has since acted as a holding company for the new healthcare companies that he has been involved in.

He was also a director in various companies listed on the Milan Stock Exchange, AIM London and NASDAQ.

Marco Mastrodonato
Founder and CEO

As the founder of BMG Pharma, he has focused creative corporate energies on innovative products that have a non-traditional profile to provide patients a safe and efficacious solution to a targeted condition in several therapeutic areas including oral care, dermatology & cancer support.

Dermal and Mucosal inflammation have been the principal areas of research and development which have led to several patents by identifying synergies between ingredients, delivery systems, and patient need.

Creating innovative products for the pharmaceutical and healthcare industries with a commitment to partnership is the primary commercial goal of the company.

Mr. Mastrodonato is the founder and former Chairman of Delife Pharma Srl, a specialty dermatology company which was acquired by the Menarini Group in 2015.

As a founder and former Executive Director of Sinclair Pharma plc which was listed on the LSE, Mr. Mastrodonato headed up the Business Development, Licensing and Product Development Division of the group for 9 years, after the 2001 Sinclair acquisition of PropharmaSrl. Mr. Mastrodonato guided Sinclair from being a branded generics company into the Dermatology, Oral Care and Cancer Support markets, with the invention and regulatory registration with the FDA and EU of two first in class medical device regulated products. During the 9 years at Sinclair, Mr. Mastrodonato contributed to several publications and posters in the R&D of Oral Care and Dermatology and was a named inventor on 10 patents.

Between 1996 and 1998, Mr. Mastrodonato worked as a consultant at Carrington Laboratories Inc., a US-based biopharmaceutical research company, specifically in licensing and importing products from the US to Europe.

Prior to 1998, Mr. Mastrodonato founded an Italian agro-chemical company, Protema SPA. Between 1989 and 1996, he led the European Operation of the clinical research organization, AAI Pharma Inc. and between 1987 and 1989, he worked for the privately-owned company OEMF SPA, publisher of the pharmaceutical directory, InformatoreFarmaceutico, a family business.

Mr. Mastrodonato’s long experience in the global pharma business has led to multiple successes in licensing, corporate development and entrepreneurship.

Roberto Bianchi
Founder and Chairman

Highly experienced pharmaceutical and healthcare executive, having started in 1974 with Ellem, a small Italian pharmaceutical company of which he became shareholder and CEO and sold successfully to PharmItalia Carlo Erba in 1986.

Between 1986-1992 he was GM and then CEO of Farmitalia Carlo Erba. He was also appointed COO and then CEO of pharmaceutical business of Erbamont, the holding company of Montedison Group which owned Farmitalia Carlo Erba.

In 1993, he founded Aquisitio S.p.a, a financial company that has since acted as a holding company for the new healthcare companies that he has been involved in.

He was also a director in various companies listed on the Milan Stock Exchange, AIM London and NASDAQ.

Marco Mastrodonato
Founder and CEO

As the founder of BMG Pharma, he has focused creative corporate energies on innovative products that have a non-traditional profile to provide patients a safe and efficacious solution to a targeted condition in several therapeutic areas including oral care, dermatology & cancer support.

Dermal and Mucosal inflammation have been the principal areas of research and development which have led to several patents by identifying synergies between ingredients, delivery systems, and patient need.

Creating innovative products for the pharmaceutical and healthcare industries with a commitment to partnership is the primary commercial goal of the company.

Mr. Mastrodonato is the founder and former Chairman of Delife Pharma Srl, a specialty dermatology company which was acquired by the Menarini Group in 2015.

As a founder and former Executive Director of Sinclair Pharma plc which was listed on the LSE, Mr. Mastrodonato headed up the Business Development, Licensing and Product Development Division of the group for 9 years, after the 2001 Sinclair acquisition of PropharmaSrl. Mr. Mastrodonato guided Sinclair from being a branded generics company into the Dermatology, Oral Care and Cancer Support markets, with the invention and regulatory registration with the FDA and EU of two first in class medical device regulated products. During the 9 years at Sinclair, Mr. Mastrodonato contributed to several publications and posters in the R&D of Oral Care and Dermatology and was a named inventor on 10 patents.

Between 1996 and 1998, Mr. Mastrodonato worked as a consultant at Carrington Laboratories Inc., a US-based biopharmaceutical research company, specifically in licensing and importing products from the US to Europe.

Prior to 1998, Mr. Mastrodonato founded an Italian agro-chemical company, Protema SPA. Between 1989 and 1996, he led the European Operation of the clinical research organization, AAI Pharma Inc. and between 1987 and 1989, he worked for the privately-owned company OEMF SPA, publisher of the pharmaceutical directory, InformatoreFarmaceutico, a family business.

Mr. Mastrodonato’s long experience in the global pharma business has led to multiple successes in licensing, corporate development and entrepreneurship.

Edoardo Richter
Board Member

As senior healthcare executive in pharmaceuticals, over 35 years of experience has been gained through a number of key companies which includes Angelini Italy, Angenerico, Hexan, and CSC Pharmaceutical Gmbh. Experience has been gained in the areas of M&A, strategic planning, marketing and business development from Japan, US, EU, and Asia. Board level experience has been gained both in Italy and internationally.

Edoardo Richter
Board Member

As senior healthcare executive in pharmaceuticals, over 35 years of experience has been gained through a number of key companies which includes Angelini Italy, Angenerico, Hexan, and CSC Pharmaceutical Gmbh. Experience has been gained in the areas of M&A, strategic planning, marketing and business development from Japan, US, EU, and Asia. Board level experience has been gained both in Italy and internationally.

Paul Phull
Chief Operating Officer

Responsible for global commercial operations of the company including business development, marketing, and sales.

Focused on developing and implementing the business development & marketing strategy for BMG products and working with global partners to ensure success in individual markets.

Over 30 years of senior-level general management, business development, and sales & marketing experience in the medical device, pharmaceutical, and biotechnology industries.

Roberto Bianchi
Founder and Chairman

Highly experienced pharmaceutical and healthcare executive, having started in 1974 with Ellem, a small Italian pharmaceutical company of which he became shareholder and CEO and sold successfully to PharmItalia Carlo Erba in 1986.

Between 1986-1992 he was GM and then CEO of Farmitalia Carlo Erba. He was also appointed COO and then CEO of pharmaceutical business of Erbamont, the holding company of Montedison Group which owned Farmitalia Carlo Erba.

In 1993, he founded Aquisitio S.p.a, a financial company that has since acted as a holding company for the new healthcare companies that he has been involved in.

He was also a director in various companies listed on the Milan Stock Exchange, AIM London and NASDAQ.

Marco Mastrodonato
Founder and CEO

As the founder of BMG Pharma, he has focused creative corporate energies on innovative products that have a non-traditional profile to provide patients a safe and efficacious solution to a targeted condition in several therapeutic areas including oral care, dermatology & cancer support.

Dermal and Mucosal inflammation have been the principal areas of research and development which have led to several patents by identifying synergies between ingredients, delivery systems, and patient need.

Creating innovative products for the pharmaceutical and healthcare industries with a commitment to partnership is the primary commercial goal of the company.

Mr. Mastrodonato is the founder and former Chairman of Delife Pharma Srl, a specialty dermatology company which was acquired by the Menarini Group in 2015.

As a founder and former Executive Director of Sinclair Pharma plc which was listed on the LSE, Mr. Mastrodonato headed up the Business Development, Licensing and Product Development Division of the group for 9 years, after the 2001 Sinclair acquisition of PropharmaSrl. Mr. Mastrodonato guided Sinclair from being a branded generics company into the Dermatology, Oral Care and Cancer Support markets, with the invention and regulatory registration with the FDA and EU of two first in class medical device regulated products. During the 9 years at Sinclair, Mr. Mastrodonato contributed to several publications and posters in the R&D of Oral Care and Dermatology and was a named inventor on 10 patents.

Between 1996 and 1998, Mr. Mastrodonato worked as a consultant at Carrington Laboratories Inc., a US-based biopharmaceutical research company, specifically in licensing and importing products from the US to Europe.

Prior to 1998, Mr. Mastrodonato founded an Italian agro-chemical company, Protema SPA. Between 1989 and 1996, he led the European Operation of the clinical research organization, AAI Pharma Inc. and between 1987 and 1989, he worked for the privately-owned company OEMF SPA, publisher of the pharmaceutical directory, InformatoreFarmaceutico, a family business.

Mr. Mastrodonato’s long experience in the global pharma business has led to multiple successes in licensing, corporate development and entrepreneurship.

Edoardo Richter
Board Member

As senior healthcare executive in pharmaceuticals, over 35 years of experience has been gained through a number of key companies which includes Angelini Italy, Angenerico, Hexan, and CSC Pharmaceutical Gmbh. Experience has been gained in the areas of M&A, strategic planning, marketing and business development from Japan, US, EU, and Asia. Board level experience has been gained both in Italy and internationally.

Paul Phull
Chief Operating Officer

Responsible for global commercial operations of the company including business development, marketing, and sales.

Focused on developing and implementing the business development & marketing strategy for BMG products and working with global partners to ensure success in individual markets.

Over 30 years of senior-level general management, business development, and sales & marketing experience in the medical device, pharmaceutical, and biotechnology industries.

Luca Stucchi
Chief Scientific Officer

Responsible for the product development activities of the company, including co-ordination and supervision of internal discovery, characterization and optimization at laboratory scale of functional ingredients, prior to development of final products. Also responsible for all regulatory activity leading to product registrations.

Paul Phull
Chief Operating Officer

Responsible for global commercial operations of the company including business development, marketing, and sales.

Focused on developing and implementing the business development & marketing strategy for BMG products and working with global partners to ensure success in individual markets.

Over 30 years of senior-level general management, business development, and sales & marketing experience in the medical device, pharmaceutical, and biotechnology industries.

Luca Stucchi
Chief Scientific Officer

Responsible for the product development activities of the company, including co-ordination and supervision of internal discovery, characterization and optimization at laboratory scale of functional ingredients, prior to development of final products. Also responsible for all regulatory activity leading to product registrations.

Claudio Alì
CFO/ Financial Advisor

More than 25 years expertise in Financial and Accounting areas in national and multinational contexts such as Telecom Italia, Patrimonio del Trentino, and Lattebusche; From 2007 till 2018 General Manager in Patrimonio del Trentino Spa company with 1 billion of assets evaluation.

Luca Stucchi
Chief Scientific Officer

Responsible for the product development activities of the company, including co-ordination and supervision of internal discovery, characterization and optimization at laboratory scale of functional ingredients, prior to development of final products. Also responsible for all regulatory activity leading to product registrations.

Claudio Alì
CFO/ Financial Advisor

More than 25 years expertise in Financial and Accounting areas in national and multinational contexts such as Telecom Italia, Patrimonio del Trentino, and Lattebusche; From 2007 till 2018 General Manager in Patrimonio del Trentino Spa company with 1 billion of assets evaluation.

Annalisa Cavalli
Business Manager

Responsible for coordinating business development and alliance management activities within the company to ensure the timely launch of products and appropriate implementation of distribution agreements.

Additional responsibilities include project management of new product development teams to ensure the timely availability of new products to the business development team.

Experienced as a project manager with full responsibility in product development within medical devices including oral care, dermatology, and gynecology.

Mike Killeen
Director of Business Development USA

Responsible for business development and regulatory activities in the USA and Canada. Activities include the development and implementation of appropriate regulatory strategies for BMG products for the North American market. Also responsible for identifying appropriate partners, concluding and implementing agreements and ensuring that partners achieve a timely launch and sales development of products.

Over 30 years of senior level experience in sales & marketing, regulatory strategy, licensing and general management in the medical device, pharmaceutical & biotechnology industries. Experience covers many markets including surgical dressings, wound care, oral care and dermatology with experience in Rx and OTC products.

Annalisa Cavalli
Business Manager

Responsible for coordinating business development and alliance management activities within the company to ensure the timely launch of products and appropriate implementation of distribution agreements.

Additional responsibilities include project management of new product development teams to ensure the timely availability of new products to the business development team.

Experienced as a project manager with full responsibility in product development within medical devices including oral care, dermatology, and gynecology.

Mike Killeen
Director of Business Development USA

Responsible for business development and regulatory activities in the USA and Canada. Activities include the development and implementation of appropriate regulatory strategies for BMG products for the North American market. Also responsible for identifying appropriate partners, concluding and implementing agreements and ensuring that partners achieve a timely launch and sales development of products.

Over 30 years of senior level experience in sales & marketing, regulatory strategy, licensing and general management in the medical device, pharmaceutical & biotechnology industries. Experience covers many markets including surgical dressings, wound care, oral care and dermatology with experience in Rx and OTC products.

Loredana Galli
Legal Director

Responsible for all commercial and corporate legal issues for the company with specific experience in negotiation and agreements between Italian and international companies.

Specific experience gained in important Italian pharmaceutical companies includes Mediolanum Farmaceutici S.p.A., Recordati S.p.a. and Nerviano Medical Sciences S.r.l.

She is a Former member of the Committee of Legal experts of Farmindustria (Italian Association of Pharmaceutical Industries) and having graduated in Law from the University of Pavia.

Claudio Alì
CFO/ Financial Advisor

More than 25 years expertise in Financial and Accounting areas in national and multinational contexts such as Telecom Italia, Patrimonio del Trentino, and Lattebusche; From 2007 till 2018 General Manager in Patrimonio del Trentino Spa company with 1 billion of assets evaluation.

Annalisa Cavalli
Business Manager

Responsible for coordinating business development and alliance management activities within the company to ensure the timely launch of products and appropriate implementation of distribution agreements.

Additional responsibilities include project management of new product development teams to ensure the timely availability of new products to the business development team.

Experienced as a project manager with full responsibility in product development within medical devices including oral care, dermatology, and gynecology.

Mike Killeen
Director of Business Development USA

Responsible for business development and regulatory activities in the USA and Canada. Activities include the development and implementation of appropriate regulatory strategies for BMG products for the North American market. Also responsible for identifying appropriate partners, concluding and implementing agreements and ensuring that partners achieve a timely launch and sales development of products.

Over 30 years of senior level experience in sales & marketing, regulatory strategy, licensing and general management in the medical device, pharmaceutical & biotechnology industries. Experience covers many markets including surgical dressings, wound care, oral care and dermatology with experience in Rx and OTC products.

Loredana Galli
Legal Director

Responsible for all commercial and corporate legal issues for the company with specific experience in negotiation and agreements between Italian and international companies.

Specific experience gained in important Italian pharmaceutical companies includes Mediolanum Farmaceutici S.p.A., Recordati S.p.a. and Nerviano Medical Sciences S.r.l.

She is a Former member of the Committee of Legal experts of Farmindustria (Italian Association of Pharmaceutical Industries) and having graduated in Law from the University of Pavia.

Chiara Ismelli
Regulatory Director and QA

Responsible for all regulatory and quality assurance activities for the company, having joined in January 2017.

Extensive experience as a Corporate Regulatory Manager for cosmetic products and Regulatory Manager for the APAC region in Sinclair Pharmaceuticals (2008-2015), subsequently for Alliance Pharmaceuticals (2015-2016). Graduated in Quality Control from the University of Eastern Piedmont.

Loredana Galli
Legal Director

Responsible for all commercial and corporate legal issues for the company with specific experience in negotiation and agreements between Italian and international companies.

Specific experience gained in important Italian pharmaceutical companies includes Mediolanum Farmaceutici S.p.A., Recordati S.p.a. and Nerviano Medical Sciences S.r.l.

She is a Former member of the Committee of Legal experts of Farmindustria (Italian Association of Pharmaceutical Industries) and having graduated in Law from the University of Pavia.

Chiara Ismelli
Regulatory Director and QA

Responsible for all regulatory and quality assurance activities for the company, having joined in January 2017.

Extensive experience as a Corporate Regulatory Manager for cosmetic products and Regulatory Manager for the APAC region in Sinclair Pharmaceuticals (2008-2015), subsequently for Alliance Pharmaceuticals (2015-2016). Graduated in Quality Control from the University of Eastern Piedmont.

Marco Mochi
Director Business Development

Responsible for global business development activities outside North America. Includes the identification of suitable partners for BMG products and negotiating and concluding agreements as appropriate. Working with partners to ensure the timely launch and sales development of products as agreed.

Experience includes more than 23 years of working actively in Licensing and Corporate Business Development at Sigma-Tau (Italy), GP Pharm and Salvat (Spain), concluding over 70 international agreements with experience in Europe, US, Canada, Brazil, Russia, China and Australasia.

Chiara Ismelli
Regulatory Director and QA

Responsible for all regulatory and quality assurance activities for the company, having joined in January 2017.

Extensive experience as a Corporate Regulatory Manager for cosmetic products and Regulatory Manager for the APAC region in Sinclair Pharmaceuticals (2008-2015), subsequently for Alliance Pharmaceuticals (2015-2016). Graduated in Quality Control from the University of Eastern Piedmont.

Marco Mochi
Director Business Development

Responsible for global business development activities outside North America. Includes the identification of suitable partners for BMG products and negotiating and concluding agreements as appropriate. Working with partners to ensure the timely launch and sales development of products as agreed.

Experience includes more than 23 years of working actively in Licensing and Corporate Business Development at Sigma-Tau (Italy), GP Pharm and Salvat (Spain), concluding over 70 international agreements with experience in Europe, US, Canada, Brazil, Russia, China and Australasia.

Marco Mochi
Director Business Development

Responsible for global business development activities outside North America. Includes the identification of suitable partners for BMG products and negotiating and concluding agreements as appropriate. Working with partners to ensure the timely launch and sales development of products as agreed.

Experience includes more than 23 years of working actively in Licensing and Corporate Business Development at Sigma-Tau (Italy), GP Pharm and Salvat (Spain), concluding over 70 international agreements with experience in Europe, US, Canada, Brazil, Russia, China and Australasia.

TEAM
Gabriella Bollea
Supply Chain & Purchaising
Rita Gianni
IP Manager
Gabriella Bollea
Supply Chain & Purchaising
Rita Gianni
IP Manager
Pierluigi D’Amelio
IT & Communication Manager
Pierluigi D’Amelio
IT & Communication Manager
Monika Hohmann
Assistant
Gabriella Bollea
Supply Chain & Purchaising
Rita Gianni
IP Manager
Pierluigi D’Amelio
IT & Communication Manager
Monika Hohmann
Assistant
Alessandra Niglio
Regulatory & QA Expert
Monika Hohmann
Assistant
Alessandra Niglio
Regulatory & QA Expert
Simona Palumbo
Executive Team Manager
Alessandra Niglio
Regulatory & QA Expert
Simona Palumbo
Executive Team Manager
Fabrizio Picotti
Laboratory Manager
Annalisa Pinciroli
Senior Accountant & HR
Fabrizio Picotti
Laboratory Manager
Annalisa Pinciroli
Senior Accountant & HR
Alessandra Sechi
Project Manager
Simona Palumbo
Executive Team Manager
Fabrizio Picotti
Laboratory Manager
Annalisa Pinciroli
Senior Accountant & HR
Alessandra Sechi
Project Manager
Milena Minardi
Jr. Regulatory & QA
Alessandra Sechi
Project Manager
Milena Minardi
Jr. Regulatory & QA
Milena Minardi
Jr. Regulatory & QA
Reza Sedaghat
Marketing & Alliance Management Associate
Lara Franchini
Executive Team Manager
Reza Sedaghat
Marketing & Alliance Management Associate
Lara Franchini
Executive Team Manager
Reza Sedaghat
Marketing & Alliance Management Associate
Lara Franchini
Executive Team Manager
Menu